Healthcare Services

Lewy Body Dementia Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Lewy Body Dementia Market At The End Of The 2026–2030 Forecast Period?

The lewy body dementia market size has shown robust growth over recent years. It is expected to expand from $1.2 billion in 2025 to $1.29 billion in 2026, at a compound annual growth rate (CAGR) of 7.2%. Historically, this growth can be ascribed to an aging population, improved recognition of dementia subtypes, greater adoption of neurological examinations, wider availability of hospital-based diagnosis, and an intensified clinical focus on cognitive decline.

The lewy body dementia market is projected for significant expansion over the coming years. Its value is anticipated to reach $1.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This projected growth is driven by factors such as enhanced diagnostic precision, the increasing prevalence of chronic neurological conditions, the expansion of specialized clinic networks, an uptick in caregiver and patient assistance initiatives, and increased healthcare expenditure dedicated to dementia care. Key trends anticipated during this period encompass the growing incidence of neurodegenerative disorders, heightened awareness and earlier identification of LBD, a greater need for precise differential diagnoses, broader application of symptom-targeted medications, and an escalating requirement for continuous care and disease management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21213&type=smp

What Drivers Are Shaping The Future Growth Of The Lewy Body Dementia Market?

The increasing occurrence of brain-related disorders is anticipated to stimulate the expansion of the lewy body dementia market moving forward. Brain-related disorders describe a spectrum of conditions that impact the brain’s structure and function, culminating in cognitive decline, memory loss, and behavioral alterations. The incidence of brain-related disorders is escalating due to elements like aging, genetic predisposition, and environmental factors. This growing prevalence of brain-related disorders enhances the need for superior treatments and prompt detection for lewy body dementia, thereby propelling research, funding, and innovation, which leads to more rapid progress in LBD diagnosis and therapy. For example, in October 2023, the World Federation of Neurology, the UK-based association of national neurological societies, stated that over 40% of the global population is impacted by neurological conditions, with this burden projected to nearly double by 2050. Thus, the escalating prevalence of brain-related disorders will drive the growth of the lewy body dementia market.

What Segment Types Make Up The Lewy Body Dementia Market?

The lewy body dementia market covered in this report is segmented –

1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis

2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications

3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users

Subsegments:

1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment

2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI)

What Key Developments And Trends Are Impacting The Lewy Body Dementia Market?

Key entities involved in the lewy body dementia market are prioritizing investment in research to create more potent neurodegenerative treatments. Research investment involves allocating financial resources, time, and effort to scientific and technological studies designed to uncover new insights, develop innovative solutions, or enhance current practices. It supports the exploration of diseases and the creation of new medications, all with the ultimate goal of improving patient outcomes. For instance, in March 2023, the National Institute on Aging, a US-based government agency, granted $21 million to support drug development research for Lewy Body Dementia (LBD). Following encouraging early results, researchers at the University of Miami Miller School of Medicine are initiating a Phase 2b study of neflamapimod.

Who Are The Key Players Driving Competition In The Lewy Body Dementia Market?

Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer’s Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.

Read the full lewy body dementia market report here:

https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-global-market-report

Which Geographic Regions Are Influencing Demand In The Lewy Body Dementia Market?

North America was the largest region in the lewy body dementia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lewy Body Dementia Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21213&type=smp

Browse Through More Reports Similar to the Global Lewy Body Dementia Market 2026, By The Business Research Company

Alzheimers Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Alzheimers Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Elderly Care Global Market Report

https://www.thebusinessresearchcompany.com/report/elderly-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795